Bookmark

Add to MyYahoo RSS

Jazz Pharmaceuticals News

News on Jazz Pharmaceuticals (Ticker: JAZZ) continually updated from thousands of sources around the net.

Thursday | AmericanBankingNews.com

Canaccord Genuity Reiterates Buy Rating for Jazz Pharmaceuticals plc

's stock had its "buy" rating restated by Canaccord Genuity in a research note issued on Thursday, Stock Ratings Network reports.

Comment?

Related Topix: Startups

Fri Apr 11, 2014

Sys-Con Media

Clinical Trial Results and Initiation, Endowment, Product Launches,...

Today, Analysts Review released its analysts' notes regarding Regeneron Pharmaceuticals, Inc. , Questcor Pharmaceuticals, Inc. , Jazz Pharmaceuticals plc , Ariad Pharmaceuticals, Inc. , and BioMarin Pharmaceutical Inc. .

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Questcor Pharmaceuticals, Startups, ARIAD Pharmaceuticals, BioMarin Pharmaceutical

Thu Apr 10, 2014

AmericanBankingNews.com

Jazz Pharmaceuticals plc CEO Unloads $615,900 in Stock

Jazz Pharmaceuticals plc CEO Bruce C. Cozadd unloaded 5,000 shares of the stock on the open market in a transaction dated Tuesday, April 8th.

Comment?

Related Topix: Startups

Wed Apr 09, 2014

Seeking Alpha

Jazz Pharma: Risk 1% Downside, 34% Upside To Fair Value

Last year was a year in which the Biotech industry could do no wrong in the eyes of the retail and institutional investor communities.

Comment?

Related Topix: Biotech, Science / Technology, Celgene, Financial Markets, Startups

Tue Apr 08, 2014

SocalTECH.com

Atara Biotherapeutics Bolsters Board, Executives

Thousand Oaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer.

Comment?

Related Topix: Startups, Onyx Pharmaceuticals

Thu Apr 03, 2014

AmericanBankingNews.com

Jazz Pharmaceuticals plc Receives Consensus Rating of "Buy" from Brokerages

Jazz Pharmaceuticals plc has been given an average recommendation of "Buy" by the seventeen brokerages that are currently covering the company, Stock Ratings Network reports .

Comment?

Related Topix: Startups

Wed Apr 02, 2014

The Motley Fool

Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?

The article states that Jazz may be willing to pay north of $20 per share for Ariad and its leukemia drug Iclusig.

Comment?

Related Topix: ARIAD Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Leukemia, Health, Healthcare Law, Law, Food and Drug Administration, Marketing, Startups

Medical News Today

European commercial launch of first approved life-saving treatment...

Jazz Pharmaceuticals plc and Gentium S.p.A., a Jazz Pharmaceuticals company, have announced the commencement of the European commercial launch of Defitelioq , the first licensed product for the treatment of severe hepatic veno-occlusive disease in patients over one month of age undergoing haematopoietic stem cell transplantation therapy.[1] The ... (more)

Comment?

Related Topix: Startups, Gentium, Stem Cell Research, Science / Technology, Medicine, Hematology

Mon Mar 31, 2014

Freshnews

Concert Pharmaceuticals Reports Year End 2013 Financial Results

Concert Pharmaceuticals, Inc. today reported financial results for the year ended December 31, 2013 and provided an update on corporate activities.

Comment?

Related Topix: Concert Pharmaceuticals, Startups, Medicine, Healthcare Law, Law, Pharmacology

Benzinga

Jazz Pharmaceuticals, Gentium Announce European Commercial Launch of Defitelio

Jazz Pharmaceuticals plc and Gentium S.p.A., a Jazz Pharmaceuticals company, today announced the commencement of the European commercial launch of DefitelioA ^a-1 4 , the first licensed product for the treatment of severe hepatic veno-occlusive disease in patients over one month of age undergoing haematopoietic stem cell transplantation therapy.

Comment?

Related Topix: Startups, Gentium, Stem Cell Research, Science / Technology

Fri Mar 28, 2014

SchaeffersResearch.com

Option Clips: Ariad Pharmaceuticals, MannKind, and Kroger

StockTwits today are oncology concern Ariad Pharmaceuticals, Inc. and biopharmaceutical issue MannKind Corporation .

Comment?

Related Topix: ARIAD Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Kroger, Retail, Grocery, MannKind, Startups, Day Trading, Financial Markets, Personal Finance

AmericanBankingNews.com

Jazz Pharmaceuticals plc Trading Down 3.5% After Analyst Downgrade

Jazz Pharmaceuticals plc 's share price dropped 3.5% during mid-day trading on Friday after Leerink Swann lowered their price target on the stock from $189.00 to $170.00, StockRatingsNetwork.com reports.

Comment?

Related Topix: Startups

AmericanBankingNews.com

Jazz Pharmaceuticals plc Price Target Cut to $170.00

Leerink Swann's price objective would indicate a potential upside of 23.19% from the stock's previous close.

Comment?

Related Topix: Startups

The Motley Fool

Morning Movers in Biotech: Ariad Pharmaceuticals, Exact Sciences Corporation and MannKind Corp

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

Comment?

Related Topix: ARIAD Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Startups, Eli Lilly, Healthcare Law, Food and Drug Administration, Law

Thu Mar 27, 2014

Daily Mail

Market Report: Drug giants fail to swallow Ariad Pharmaceuticals

As shares of UK pharmaceutical giants GlaxoSmithKline shed 9.5p to 1,614p and Shire declined 20p to 3,035p, dealers heard that both had lost out in the auction for Massachusetts-based Ariad Pharmaceuticals.

Comment?

Related Topix: ARIAD Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Startups

Fri Mar 21, 2014

BioSpace

Entrepreneur Cashes In $86 Million Of Jazz Pharmaceuticals plc To Fund New Venture

Entrepreneur Seamus Mulligan has cashed in shares worth $86 million in Jazz Pharmaceuticals which will entirely be used to fund a new business called Adapt Pharma.

Comment?

Related Topix: Startups

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••